Real-World Efficacy of Intravitreal Faricimab for Macular Edema Secondary to Retinal Vein Occlusion: Short-Term Outcomes and Optical Coherence Tomography Biomarker Analysis
Intravitreal faricimab was effective and well-tolerated for RVO-ME in this real-world study. Even a single injection frequently led to anatomical and functional improvement. These results support the clinical utility of faricimab and suggest a potential role for OCT biomarkers in predicting treatment response.
Authors
- Takahiko Hayashi (ORCID: https://orcid.org/0000-0001-8704-680X)
- Nobuhisa Mizuki (ORCID: https://orcid.org/0000-0003-3738-8777)
- Junji Onishi
- Yuki Mizuki (ORCID: https://orcid.org/0000-0003-3722-0659)
- Sadaki Inokuchi (ORCID: https://orcid.org/0000-0001-7320-2170)
- A Kamata
Institutions
- Nihon University (JP)
- Yokohama Minami Kyosai Hospital (JP)
- International Goodwill Hospital (JP)
- Yokohama City University (JP)
Publication Details
- Journal
- Clinical ophthalmology
- Published
- 2025-10-01
- DOI
- https://doi.org/10.2147/opth.s549896
- Citations
- 1
- Primary Topic
- Retinal and Optic Conditions
- Type
- article
- Field-Weighted Citation Impact
- 1.71